Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
131.57
-1.57 (-1.18%)
Mar 31, 2025, 9:40 AM EDT - Market open
Tenet Healthcare Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$164.00
Upside
+24.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $165 | Buy | Initiates | $165 | +25.41% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $177 | Buy | Reiterates | $177 | +34.53% | Feb 13, 2025 |
| Barclays | Barclays | Buy Maintains $190 → $161 | Buy | Maintains | $190 → $161 | +22.37% | Feb 13, 2025 |
| Keybanc | Keybanc | Buy Maintains $200 → $185 | Buy | Maintains | $200 → $185 | +40.61% | Jan 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $190 → $175 | Strong Buy | Maintains | $190 → $175 | +33.01% | Jan 6, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $175 | Buy | Initiates | $175 | +33.01% | Dec 17, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $196 → $140 | Strong Buy → Hold | Downgrades | $196 → $140 | +6.41% | Dec 16, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $205 → $150 | Buy → Hold | Downgrades | $205 → $150 | +14.01% | Nov 25, 2024 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $195 | Strong Buy → Buy | Downgrades | $195 | +48.21% | Nov 22, 2024 |
| Barclays | Barclays | Buy Maintains $171 → $190 | Buy | Maintains | $171 → $190 | +44.41% | Nov 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $195 → $205 | Buy | Maintains | $195 → $205 | +55.81% | Nov 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $168 → $177 | Buy | Maintains | $168 → $177 | +34.53% | Oct 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $173 → $196 | Strong Buy | Maintains | $173 → $196 | +48.97% | Oct 30, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $174 → $183 | Buy | Maintains | $174 → $183 | +39.09% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $180 → $190 | Strong Buy | Reiterates | $180 → $190 | +44.41% | Oct 30, 2024 |
| UBS | UBS | Strong Buy Maintains $197 → $217 | Strong Buy | Maintains | $197 → $217 | +64.93% | Oct 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.